✦ LIBER ✦

Safety and Efficacy of Mipomersen Administered as Add-on Therapy in Patients with Hypercholesterolemia and High Cardiovascular Risk†

✍ Scribed by William C. Cromwell; Gregory S. Thomas; Ingrid Boltje; Wai Chin; Michael Davidson

Book ID: 118460864
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 71 KB
Volume: 6
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2012.04.072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SAFETY AND EFFICACY OF MIPOMERSEN ADMINI

SAFETY AND EFFICACY OF MIPOMERSEN ADMINISTERED AS ADD-ON THERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND HIGH CARDIOVASCULAR RISK

✍ William C. Cromwell; Gregory S. Thomas; Ingrid Boltje; Wai Chin; Michael Davidso 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Long-Term Safety and Efficacy of Mipomer

Long-Term Safety and Efficacy of Mipomersen in Patients with Familial Hypercholesterolemia Uncontrolled by Maximally Tolerated Lipid Lowering Therapy

✍ P. Barton Duell; Raul D. Santos; Cara East; John R. Guyton; Patrick M. Moriarty; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 48 KB

Achieving lipoprotein goals in patients

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin

✍ E. Stein; S. Stender; P. Mata 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Achieving lipoprotein goals in patients

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin

✍ Evan Stein; Steen Stender; Pedro Mata; Philip Sager; Damien Ponsonnet; Lorenzo M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Efficacy and safety evaluation of lorecl

Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients

✍ T Rentmeester; J Hulsman 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. The trial lasted 6 months. Loreclezole was dosed to reach a target plasma concentration between 1 and 3 mg/l. The seizure frequency in the total group decreased by 23%. A reduction of 50% or more was observed in four p

Long-term safety and efficacy of gabapen

Long-term safety and efficacy of gabapentin (neurontin) as add-on therapy in patients with refractory partial seizures

✍ Henning Anhut; Philip J Ashman; Thomas J Feuerstein; Erhard Quebe-Fehling; Maria 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 588 KB